Multiple Sclerosis Clinical Trial

Safety Study of SPARC1104

Summary

Open-label, safety study of SPARC1104 in subjects with spasticity due to multiple sclerosis

View Full Description

Full Description

Safety study of SPARC1104

View Eligibility Criteria

Eligibility Criteria

Willingness to participate and give written informed consent
Men and women ≥ 18 years of age
Sexually active women who are of child bearing potential will practice an acceptable method of birth control for the duration of the trial as judged by the investigator. Examples of acceptable contraception are: condoms, foams, jellies, diaphragm, intrauterine device, oral or long-acting injected contraceptives, bilateral tubal ligation, bilateral oophorectomy, hysterectomy, or having a partner who is incapable of initiating conception. The practice of contraception must have started at least 3 months prior to trial entry.
If female, negative pregnancy test result at Screening
Diagnosed with MS and a known history of spasticity
Meet one of the following criteria o Subjects who completed the double-blind randomized withdrawal phase (Part 3) of trial CLR_09_21 with no major protocol violation

Study is for people with:

Multiple Sclerosis

Phase:

Phase 3

Estimated Enrollment:

375

Study ID:

NCT01797185

Recruitment Status:

Completed

Sponsor:

Sun Pharma Advanced Research Company Limited

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 51 Locations for this study

See Locations Near You

SPARC site 4
Gilbert Arizona, 85234, United States
SPARC Site 34
Phoenix Arizona, 85004, United States
SPARC Site 1
Tucson Arizona, 85704, United States
SPARC Site 30
Costa Mesa California, 92626, United States
SPARC Site 14
Newport Beach California, 92663, United States
SPARC Site 32
Basalt Colorado, 81621, United States
SPARC Site 5
Denver Colorado, 80209, United States
SPARC Site 7
Derby Connecticut, 06418, United States
SPARC site 47
Hartford Connecticut, 06112, United States
SPARC Site 8
New London Connecticut, 06320, United States
SPARC Site 50
Washington District of Columbia, 20007, United States
SPARC Site 35
Maitland Florida, 32751, United States
SPARC Site 59
Miami Florida, 33136, United States
SPARC Site 6
Ormond Beach Florida, 32174, United States
SPARC Site 11
Port Charlotte Florida, 33952, United States
SPARC Site 13
Sarasota Florida, 34233, United States
SPARC Site 25
Sunrise Florida, 33351, United States
SPARC Site 55
Tampa Florida, 33612, United States
SPARC Site 33
Tampa Florida, 33634, United States
SPARC site 45
Lenexa Kansas, 66214, United States
SPARC Site 24
Overland Park Kansas, 66212, United States
SPARC Site 44
Louisville Kentucky, 40207, United States
SPARC site 36
Alexandria Louisiana, 73101, United States
SPARC Site 21
Baton Rouge Louisiana, 70810, United States
SPARC Site 61
New Orleans Louisiana, 70121, United States
SPARC Site 49
Baltimore Maryland, 21287, United States
SPARC Site 22
Fulton Maryland, 20759, United States
SPARC Site 29
Foxboro Massachusetts, 02035, United States
SPARC Site 17
Springfield Massachusetts, 01104, United States
SPARC Site 26
Clinton Township Michigan, 48035, United States
SPARC Site 54
Detroit Michigan, 48202, United States
SPARC Site 19
Golden Valley Minnesota, 55422, United States
SPARC Site 28
Flemington New Jersey, 08822, United States
SPARC Site 16
Albuquerque New Mexico, 87108, United States
SPARC Site 43
Rochester New York, 14642, United States
SPARC Site 52
White Plains New York, 10605, United States
SPARC site 39
Charlotte North Carolina, 28203, United States
SPARC Site 18
Greensboro North Carolina, 27405, United States
SPARC Site 2
Winston-Salem North Carolina, 27103, United States
SPARC Site 27
Centerville Ohio, 45459, United States
SPARC site 10
Eugene Oregon, 97041, United States
SPARC site 38
Springfield Oregon, 97477, United States
SPARC Site 57
Abington Pennsylvania, 19090, United States
SPARC Site 23
Indian Land South Carolina, 29707, United States
SPARC Site 5
Austin Texas, 78731, United States
SPARC Site 60
Dallas Texas, 75246, United States
SPARC Site 37
Houston Texas, 77025, United States
SPARC Site 20
Tacoma Washington, 98405, United States
SPARC Site 62
Huntington West Virginia, 25701, United States
SPARC Site 58
Milwaukee Wisconsin, 53215, United States
SPARC Site 56
Waukesha Wisconsin, 53188, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Phase:

Phase 3

Estimated Enrollment:

375

Study ID:

NCT01797185

Recruitment Status:

Completed

Sponsor:


Sun Pharma Advanced Research Company Limited

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider